Complex Case of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multidisciplinary Approach to Diagnosis and Management

Authors

  • Touqeer Anjum Programmatic Management of Drug Resistant TB Unit, Lady Reading Hospital, Peshawar – Pakistan
  • Shafaq Zahoor Sarhad University of Science and Technology, Peshawar

DOI:

https://doi.org/10.1996/pjcm.v28i2.891

Keywords:

Scleroderma, ILD, Systemic Sclerosis

Abstract

Systemic sclerosis (SSc), commonly known as scleroderma, is a rare and complex autoimmune disease that can affect multiple organ systems, including the skin and lungs. Interstitial lung disease (ILD) is a frequent and severe pulmonary complication of SSc, often associated with poor outcomes. We present a challenging case of a 42-year-old female with SSc-associated ILD, highlighting the importance of a multidisciplinary approach in both diagnosis and management.

References

Giacomelli R, Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F, et al. Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol. Int. 2017;37(6):853-863.

Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med. 2020;201(6):650-660.

Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. European Respiratory Review. 2018;27(150).

Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, et al. The need for a holistic approach for SSc-ILD–achievements and ambiguity in a devastating disease. Res Res. 2020;21(1):1-3.

Asano Y, Sato S. Vasculopathy in scleroderma. InSeminars in immunopathology 2015;37:489-500. Springer Berlin Heidelberg.

Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Resp Res. 2019;20:1-0.

Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Exp Rev Clin Immun. 2018;14(1):69-82.

Wells AU. Interstitial lung disease in systemic sclerosis. La Presse Médicale. 2014;43(10):e329-43.

Johannson KA, Chaudhuri N, Adegunsoye A, Wolters PJ. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021;398(10309):1450-60.

Downloads

Published

2022-06-02

How to Cite

Anjum, T. ., & Shafaq Zahoor. (2022). Complex Case of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multidisciplinary Approach to Diagnosis and Management. Pakistan Journal of Chest Medicine, 28(2), 263–266. https://doi.org/10.1996/pjcm.v28i2.891

Issue

Section

Case Report